Edge Pharma, LLC is recalling 71 syringes of Methotrexate, USP Sterile Solution for Injection (125mg/5ml). This recall was initiated because the media used to perform required sterility testing after the drug was compounded had expired, meaning the company cannot guarantee the product is free from contamination. Methotrexate is a prescription medication often used for serious conditions like cancer or rheumatoid arthritis, and a lack of sterility in an injectable drug can lead to life-threatening infections. These syringes were distributed nationwide across the United States.
If an injectable medication is not sterile, it can introduce bacteria or fungi directly into the bloodstream or muscle tissue, potentially causing severe systemic infections, sepsis, or localized abscesses.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.